Companies in the biotechnology industry create drugs and diagnostic technologies that treat diseases. Before receiving potential FDA approval, these products must undergo rigorous, expensive,...
Pfizer and BioNTech proclaimed that their coronavirus vaccine is safe, efficient, and provides potent antibodies in children aged 12 to 15, which will enable...
NovavaxInc (NVAX) announced phase III research data of its coronavirus vaccine COVID-19. The NVX-CoV 2373 vaccine was found to be 89 % effective. The...
Pfizer (PFE) and BioNTech (BNTX) plan to produce 2 billion doses of the coronavirus vaccine this year, instead of 1.3 billion doses initially planned,...
The U.S. and German Biotech’s are aiming to obtain the clearance for their potential coronavirus vaccine. The EU authorization will allow Pfizer-BioNTech to supply...